About: Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.36 (-7.95%)
ANEBNASDAQAnebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc share price
ANEB price activity
Last Price
$0.360
Change (24hr)
-0.03 USD (-7.95%)
Volume
100
Volume (4w avg)
-
Open
$0.36
Day Range
$0.36 - $0.36
Previous Close
$0.39
Last Trade
04 Sep, 1:30 pm GMT+0
Delayed
04 Sep, 1:30 pm GMT+0
ANEB price performance
Delayed
04 Sep, 1:30 pm GMT+0
ANEB Market Signals